feed,title,long_url,short_url
Benzinga,FDA Expands Use Of Global Blood' Sickle Cell Treatment To Kids Aged 4-12 Years,https://benzinga.com/general/biotech/21/12/24693190/fda-expands-use-of-global-blood-sickle-cell-treatment-to-kids-aged-4-12-years,https://j.mp/3pbFvTS
